Xiaoli Wu

机构：Guiyang College of Traditional Chinese Medicine, Guiyang Medical University, Hohai University, Zhengzhou University, Guiyang University, Hunan Provincial Maternal and Child Health Hospital, Southeast University, Xinjiang University · ORCID：0000-0003-1601-731X

发表论文 257 篇 · 总被引 5731 次 · h-index 42

代表论文

• Ceftazidime/avibactam versus polymyxin B in carbapenem-resistant Klebsiella pneumoniae infections: a propensity score-matched multicenter real-world study (2024 · Infection · 被引 75)
• Synergistic anti-oxidative/anti-inflammatory treatment for acute lung injury with selenium based chlorogenic acid nanoparticles through modulating Mapk8ip1/MAPK and Itga2b/PI3k-AKT axis (2025 · Journal of Nanobiotechnology · 被引 27)
• Next-generation biomass nanocomposites for heavy metal ion adsorption: innovations and environmental impact (2025 · Separation and Purification Technology · 被引 22)
• The efficacy and safety of ceftazidime/avibactam or polymyxin B based regimens for carbapenem-resistant Pseudomonas aeruginosa infection: a multicenter real-world and propensity score-matched study (2025 · Frontiers in Pharmacology · 被引 17)
• A multipronged strategy for encephalitis: Oxidative stress reduction and inflammatory microenvironment modulation by a neuroprotective selenium-based nanomedicine (2024 · Chemical Engineering Journal · 被引 13)
• Fluorescent identification of immunomagnetically captured CTCs using triplex-aptamer-targeted dendritic SiO2@Fe3O4 nanocomposite (2024 · Microchimica Acta · 被引 5)